Sitryx Alternatives & Competitors
12 companies similar to Sitryx — Harnessing the power of cell metabolism to develop groundbreaking disease-modify...
Companies similar to Sitryx
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Immunitas Therapeutics
The Human Approach to Oncology
Waltham, United States
Rival Readout
Competing with Sitryx? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Onchilles Pharma
Developing drug candidates that have the potential to be broadly effective against a wide...
San Diego, United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Azome Therapeutics
Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases
Pannex Therapeutics Inc.
We are the Pannexin people.
New York, United States
ImmunoMet Therapeutics, Inc.
Targeting Metabolic Reprogramming in Fibrosis and Oncology
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
Ractigen Therapeutics
Turn on genes and turn off diseases
Suzhou, China
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
About Sitryx
Sitryx is a dynamic player in the biopharmaceutical sector, leveraging the innovative capabilities of cell metabolism to pioneer novel, disease-modifying therapies focused on immuno-oncology and immuno-inflammation. Founded in 2018, the company operates from its headquarters in Oxford, UK. The core of Sitryx’s expertis...
Developing novel oral therapies, Restoring immune balance, Disease remission through precision immunology
Patients with autoimmune and inflammatory diseases, Global biopharmaceutical companies seeking strategic partnerships
Biopharmaceutical, Cell Metabolism, Disease-modifying Therapeutics, Immuno-oncology, Immuno-inflammation, Immunometabolism, Drug Discovery, Therapeutics Development, Biotech Startup, Innovative Therapeutics, Pharmaceutical R&D, Early-stage Biotech, Scientific Research Collaboration, Venture-backed Biotech, Specialist Investors
B2B, B2D
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Sitryx: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Sitryx on 6 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
